Nirmatrelvir Loaded Liposomes(Lipo-013RG)
| Product Summary | |
|---|---|
| Name | Nirmatrelvir Loaded Liposomes |
Download Datasheet
|
|
| Cat No. | Lipo-013RG |
| Product Overview | Nirmatrelvir (PF-07321332) is an reversible covalent inhibitor of SARS-CoV-2 main protease (Mpro, also referred to as 3CL protease) with an ki of 3.11 nM. PF-07321332 binds directly to the catalytic cysteine (Cys145) residue of the enzyme. This product is a PEG modified pre-formulated liposome with Nirmatrelvir (PF-07321332) loaded. It is supplied ready to use in vitro or in vivo studies. |
| Lipid Composition | / |
| Active Ingredients | Nirmatrelvir |
| Form | Liquid |
| Storage Buffer | 292 mM sucrose, 0.5% DPBS (1X) |
| Concentration | 10.0 mg/mL (± ~5%) (Concentration Nirmatrelvir); Lipid Concentration 60 mM |
| Stability | At least 1 month |
| Storage | 2 °C to 8 °C (do not freeze) |
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
Can you provide information on the size and composition of your liposomes?
Yes, we offer detailed specifications for each product, enabling researchers to select liposomes that best match their experimental requirements.
-
Do you offer customization options for liposome formulations?
Yes, we offer customization services to meet the unique demands of research projects. Our team of experts can work with customers to develop custom liposome formulations tailored to their specific needs, ensuring optimal results for their experiments.
-
What analytical and characterization data do you provide with your liposome products?
We provide comprehensive analytical and characterization data for all our liposome products, such as size distribution, zeta potential, and encapsulation efficiency.
